首页> 外文期刊>Nature >Theileria parasites secrete a prolyl isomerase to maintain host leukocyte transformation
【24h】

Theileria parasites secrete a prolyl isomerase to maintain host leukocyte transformation

机译:泰勒虫寄生虫分泌脯氨酰异构酶以维持宿主白细胞转化

获取原文
获取原文并翻译 | 示例
       

摘要

Infectious agents develop intricate mechanisms to interact with host cell pathways and hijack their genetic and epigenetic machinery to change host cell phenotypic states. Among the Apicomplexa phylum of obligate intracellular parasites, which cause veterinary and human diseases, Theileria is the only genus that transforms its mammalian host cells. Theileria infection of bovine leukocytes induces proliferative and invasive phenotypes associated with activated signalling pathways, notably JNK and AP-1 (ref. 2). The transformed pheno-types are reversed by treatment with the theilericidal drug bupar-vaquone. We used comparative genomics to identify a homologue of the peptidyl-prolyl isomerase PIN1 in T. annulata (TaPIN1) that is secreted into the host cell and modulates oncogenic signalling pathways. Here we show that TaPIN1 is a bona fide prolyl isomerase and that it interacts with the host ubiquitin ligase FBW7, leading to its degradation and subsequent stabilization of c-JUN, which promotes transformation. We performed in vitro and in silico analysis and in vivo zebrafish xenograft experiments to demonstrate that TaPIN1 is directly inhibited by the anti-parasite drug bupar-vaquone (and other known PIN1 inhibitors) and is mutated in a drug-resistant strain. Prolyl isomerization is thus a conserved mechanism that is important in cancer and is used by Theileria parasites to manipulate host oncogenic signalling.%泰勒虫属的原生动物寄生虫对牛具有致病性。在真核寄生虫中独特的是,泰勒虫能转变寄主的白细胞,产生与JNK和AP-1信号传导通道相关的、具有增殖和侵袭能力的表现型。这种转变可以通过抗泰勒虫药物"Buparvaquone"逆转。在这项研究中,Justine Marsolier等人识别出"肽酰脯氦酰异构酶PIN1"在环形泰勒虫(Theileria annulata)中的一个同源物(TaPIN1),发现它被分泌到寄主细胞中,在其中它与寄主的泛素连接酶FBW7发生相互作用,导致c-JUN被稳定,这会促进转变。作者利用体外和活体斑马鱼异种移植实验还发现TaPINM能被"Buparvaquone"直接抑制,同时也显示TaPIN1在一个抗药性的种系中发生了突变。这项研究显示了寄生虫与寄主致癌通道之间一个令人意外的联系。
机译:传染原发展出与宿主细胞途径相互作用并劫持其遗传和表观遗传机制以改变宿主细胞表型状态的复杂机制。在引起兽医和人类疾病的专性细胞内寄生虫的顶杆门中,泰勒氏菌是唯一能转化其哺乳动物宿主细胞的属。牛白细胞的泰勒氏菌感染会诱导与激活的信号通路相关的增殖和侵袭性表型,特别是JNK和AP-1(参考文献2)。转化的表型通过用杀虫药bupar-vaquone处理而逆转。我们使用比较基因组学来鉴定在环孢菌中的肽基-脯氨酰异构酶PIN1(TaPIN1)的同系物,该同系物被分泌到宿主细胞中并调节致癌信号通路。在这里,我们显示TaPIN1是真正的脯氨酰异构酶,并且它与宿主泛素连接酶FBW7相互作用,从而导致其降解和随后的c-JUN稳定,从而促进了转化。我们进行了体外和计算机模拟分析以及体内斑马鱼异种移植实验,以证明TaPIN1直接被抗寄生虫药物bupar-vaquone(和其他已知的PIN1抑制剂)抑制,并在耐药菌株中发生突变。因此,脯氨酰异构化是一种在癌症中很重要的保守机制,泰勒虫寄生虫利用它来操纵宿主致癌信号。%泰勒虫属的原生动物寄生虫对牛具有致病性。在真核寄生虫中独特的是,泰勒虫能转变寄主的白细胞,产生与JNK和AP-1信号通道相关的,具有发展和侵袭能力的表现型。这种转变可以通过抗泰勒虫药物“ Buparvaquone”逆转。在此研究中, Justine Marsolier等人识别出“肽取代的脯氨酸丙二醛替代酶PIN1”在环形泰勒虫(Theileria annulata)中的一个同源物(TaPIN1),发现它被复制到寄主细胞中,在其中它与寄主的作者利用体外和活体斑马鱼异种移植实验还发现TaPINM能被“ Buparvaquone”直接抑制,同时也显示TaPIN1在一个抗药性的种系中发生了突变。这次研究显示了寄生虫与寄主致癌通道之间一个令人意外的联系。

著录项

  • 来源
    《Nature》 |2015年第7547期|378-382c5|共6页
  • 作者单位

    Universite Paris Diderot, Sorbonne Paris Cite, Epigenetics and Cell Fate, UMR 7216 CNRS, 75013 Paris, France;

    Universite Paris Diderot, Sorbonne Paris Cite, Epigenetics and Cell Fate, UMR 7216 CNRS, 75013 Paris, France;

    Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, Georgia 30602, USA;

    Universite Paris Diderot, Sorbonne Paris Cite, MoleculesTherapeutiques in silico, INSERM UMR-S 973, 75013 Paris, France;

    INSERM, UMR 866, Equipe labellisee Ligue contre le Cancer and Laboratoire d'Excellence LipSTIC, 21000 Dijon, France,University of Burgundy, Faculty of Medicine and Pharmacy, 21000 Dijon, France;

    INSERM, UMR 866, Equipe labellisee Ligue contre le Cancer and Laboratoire d'Excellence LipSTIC, 21000 Dijon, France,University of Burgundy, Faculty of Medicine and Pharmacy, 21000 Dijon, France;

    INSERM, UMR 866, Equipe labellisee Ligue contre le Cancer and Laboratoire d'Excellence LipSTIC, 21000 Dijon, France,University of Burgundy, Faculty of Medicine and Pharmacy, 21000 Dijon, France,Centre anticancereux George Francois Leclerc, CGFL, 21000 Dijon, France;

    Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA;

    Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA;

    Universite Paris Diderot, Sorbonne Paris Cite, Epigenetics and Cell Fate, UMR 7216 CNRS, 75013 Paris, France;

    Universite Paris Diderot, Sorbonne Paris Cite, Epigenetics and Cell Fate, UMR 7216 CNRS, 75013 Paris, France;

    Laboratoire de Parasitologie, Ecole Nationale de Medecine Veterinaire, Universite de la Manouba, 2020 Sidi Thabet, Tunisia;

    Universite Paris Diderot, Sorbonne Paris Cite, Epigenetics and Cell Fate, UMR 7216 CNRS, 75013 Paris, France;

    Universite Paris Diderot, Sorbonne Paris Cite, Epigenetics and Cell Fate, UMR 7216 CNRS, 75013 Paris, France;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 02:52:30

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号